Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

837 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Intranasal lysine aspirin in recurrent nasal polyposis.
Scadding GK, Hassab M, Darby YC, Lund VJ, Freedman A. Scadding GK, et al. Among authors: freedman a. Clin Otolaryngol Allied Sci. 1995 Dec;20(6):561-3. doi: 10.1111/j.1365-2273.1995.tb01603.x. Clin Otolaryngol Allied Sci. 1995. PMID: 8665721 Clinical Trial.
Twenty patients with recurrent nasal polyposis but without any history of aspirin sensitivity were given 2000 micrograms of intranasal lysine aspirin to one nostril and saline to the other once a week for periods of up to 15 months. ...Polyp recurrence was bilateral but th …
Twenty patients with recurrent nasal polyposis but without any history of aspirin sensitivity were given 2000 micrograms of intranasal lysin …
The histological effects on the guinea pig external ear of several constituents of commonly used aural preparations.
Monkhouse WS, Moran P, Freedman A. Monkhouse WS, et al. Among authors: freedman a. Clin Otolaryngol Allied Sci. 1988 Apr;13(2):121-31. doi: 10.1111/j.1365-2273.1988.tb00752.x. Clin Otolaryngol Allied Sci. 1988. PMID: 2970902
The efficacy of ceruminolytics.
Freedman A. Freedman A. J Otolaryngol. 1990 Apr;19(2):150-1. J Otolaryngol. 1990. PMID: 2161465 No abstract available.
Aspirin use and p53 expression in colorectal cancer.
Freedman AN, Michalek AM, Weiss HA, Zhang ZF, Marshall JR, Mettlin CJ, Asirwatham JE, Petrelli NJ, Caporaso NE. Freedman AN, et al. Cancer Detect Prev. 1998;22(3):213-8. doi: 10.1046/j.1525-1500.1998.0oa29.x. Cancer Detect Prev. 1998. PMID: 9618042
We set out to determine whether p53 overexpression of the colorectum was associated with a patient's history of aspirin use. ...There was little evidence of a difference in the effect of aspirin use on cancer risk between cases with and without p53 overexpression, e …
We set out to determine whether p53 overexpression of the colorectum was associated with a patient's history of aspirin use. ...There …
Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma.
Burke L, Flieder DB, Guinee DG, Brambilla E, Freedman AN, Bennett WP, Jones RT, Borkowski A, Caporaso NA, Fleming M, Trastek V, Pairolero P, Tazelaar H, Midthun D, Jett JR, Liotta LA, Travis WD, Harris CC. Burke L, et al. Among authors: freedman an. Clin Cancer Res. 2005 Jan 1;11(1):232-41. Clin Cancer Res. 2005. PMID: 15671551
Cyclin D1 overexpression in pRb-negative tumors revealed a significantly worse prognosis with a mean survival of 2.3 years (P = 0.004). A simultaneous p53 mutation dramatically reduced the mean survival time to 0.9 years (P = 0.007). Cyclin D1 overexpression …
Cyclin D1 overexpression in pRb-negative tumors revealed a significantly worse prognosis with a mean survival of 2.3 years (P …
p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer.
Przygodzki RM, Bennett WP, Guinee DG Jr, Khan MA, Freedman A, Shields PG, Travis WD, Jett JR, Tazelaar H, Pairolero P, Trastek V, Liotta LA, Harris CC, Caporaso NE. Przygodzki RM, et al. Among authors: freedman a. Pharmacogenetics. 1998 Dec;8(6):503-11. doi: 10.1097/00008571-199812000-00007. Pharmacogenetics. 1998. PMID: 9918134
Incidence of colorectal carcinoma in the U.S.: an update of trends by gender, race, age, subsite, and stage, 1975-1994.
Troisi RJ, Freedman AN, Devesa SS. Troisi RJ, et al. Among authors: freedman an. Cancer. 1999 Apr 15;85(8):1670-6. Cancer. 1999. PMID: 10223559
RESULTS: Recent data have continued to show a decrease in incidence rates of total colorectal carcinoma in whites since the mid-1980s, particularly for the distal colon and rectum. ...
RESULTS: Recent data have continued to show a decrease in incidence rates of total colorectal carcinoma in whites since the mid-1980s …
Familial and nutritional risk factors for p53 overexpression in colorectal cancer.
Freedman AN, Michalek AM, Marshall JR, Mettlin CJ, Petrelli NJ, Black JD, Zhang ZF, Satchidanand S, Asirwatham JE. Freedman AN, et al. Cancer Epidemiol Biomarkers Prev. 1996 Apr;5(4):285-91. Cancer Epidemiol Biomarkers Prev. 1996. PMID: 8722220
Only cruciferous vegetables exhibited a significant inverse association (OR, 0.59; 95% CI, 0.34-1.02; trend test, P = 0.03) for the highest versus lowest quartiles. ...Cruciferous vegetables exhibited a significant association (OR, 0.37; 95% CI, 0.17-0.82; trend tes …
Only cruciferous vegetables exhibited a significant inverse association (OR, 0.59; 95% CI, 0.34-1.02; trend test, P = 0.03) for the h …
The relationship between smoking exposure and p53 overexpression in colorectal cancer.
Freedman AN, Michalek AM, Marshall JR, Mettlin CJ, Petrelli NJ, Zhang ZF, Black JD, Satchidanand S, Asirwatham JE. Freedman AN, et al. Br J Cancer. 1996 Apr;73(8):902-8. doi: 10.1038/bjc.1996.180. Br J Cancer. 1996. PMID: 8611424 Free PMC article.
A total of 163 colorectal cancer cases and 326 healthy controls responded to a standardised questionnaire on colorectal cancer risk factors including detailed information on their history of cigarette smoking. ...Estimating the individual relative risk of developing
A total of 163 colorectal cancer cases and 326 healthy controls responded to a standardised questionnaire on colorectal cancer
Prognostic significance of p53, PCNA, and c-erbB-2 in endometrial enocarcinoma.
Heffner HM, Freedman AN, Asirwatham JE, Lele SB. Heffner HM, et al. Among authors: freedman an. Eur J Gynaecol Oncol. 1999;20(1):8-12. Eur J Gynaecol Oncol. 1999. PMID: 10422671
Thirty-two percent of tumors expressed p53, 39% displayed a PCNA index of > = 25%, and 69% expressed c-erbB-2. p53 overexpression was significantly associated with stage (p=0.027), PCNA index > = 25% (p=0.005), c-erbB-2 expression (p=0.018), and vital status (p=0.04) …
Thirty-two percent of tumors expressed p53, 39% displayed a PCNA index of > = 25%, and 69% expressed c-erbB-2. p53 overexpression …
837 results
Jump to page
Feedback